Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Introduction<p>T cell receptor-engineered T cell therapy has emerged as a promising approach in cancer immunotherapy, leveraging the ability of T cells to recognize tumor antigens presented on major histocompatibility complex molecules, offering a targeted approach for treating cancers. This s...

全面介绍

Saved in:

书目详细资料
主要作者:	Saleh Alrhmoun (19193851) (author)
其他作者:	Roman Perik-Zavodskii (19193839) (author), Marina Fisher (19828437) (author), Julia Lopatnikova (4164058) (author), Olga Perik-Zavodskaia (19193842) (author), Julia Shevchenko (19193845) (author), Kirill Nazarov (19193854) (author), Julia Philippova (19828440) (author), Vasily Kurilin (19828443) (author), Olga Kichakova (22680860) (author), Evgenii Zavjalov (12230774) (author), Elena Golikova (472121) (author), Petr Timashev (10031740) (author), Petr Glybochko (13011754) (author), Sergey Sennikov (4164055) (author)
出版:	2025
主题:	Genetic Immunology TCR-T cells TCR-T T cells adoptive cell therapy her2/neu ErbB2 ScRNA-seq
标签:	添加标签没有标签, 成为第一个标记此记录!

Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

相似书籍